Skip to content

Bristol Myers Squibb announces voluntary licenses for atazanavir in India and South Africa

CROI: Abacavir gene testing reveals high levels of hypersensitivity mutation

CROI: Etravirine (TMC125) and darunavir (TMC114) in treatment-experienced patients

CROI: Atazanavir and atazanavir/ritonavir safe and effective in treatment-naive patients

CROI: Disappointment for glitazones, metformin and testosterone for body fat changes

CROI: Risk of new illnesses declines sharply after first two months on treatment in resource-limited settings

CROI News Feature: Experts divided over the future of treatment interruptions

CROI: Greater declines in TB incidence observed with long-term antiretroviral therapy

CROI: Capsaicin patch helps relieve neuropathy